Health Catalyst Statistics
Total Valuation
Health Catalyst has a market cap or net worth of $127.94 million. The enterprise value is $194.47 million.
| Market Cap | 127.94M |
| Enterprise Value | 194.47M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Health Catalyst has 75.26 million shares outstanding. The number of shares has increased by 10.32% in one year.
| Current Share Class | 75.26M |
| Shares Outstanding | 75.26M |
| Shares Change (YoY) | +10.32% |
| Shares Change (QoQ) | +1.88% |
| Owned by Insiders (%) | 5.26% |
| Owned by Institutions (%) | 64.22% |
| Float | 60.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.44 |
| Forward PS | 0.62 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 3.81 |
| P/FCF Ratio | 4.73 |
| P/OCF Ratio | 4.53 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.52, with an EV/FCF ratio of 7.20.
| EV / Earnings | n/a |
| EV / Sales | 0.67 |
| EV / EBITDA | 16.52 |
| EV / EBIT | n/a |
| EV / FCF | 7.20 |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 1.69.
| Current Ratio | 2.70 |
| Quick Ratio | 1.58 |
| Debt / Equity | 1.69 |
| Debt / EBITDA | 13.59 |
| Debt / FCF | 6.29 |
| Interest Coverage | -1.15 |
Financial Efficiency
Return on equity (ROE) is -118.12% and return on invested capital (ROIC) is -3.72%.
| Return on Equity (ROE) | -118.12% |
| Return on Assets (ROA) | -3.02% |
| Return on Invested Capital (ROIC) | -3.72% |
| Return on Capital Employed (ROCE) | -8.82% |
| Weighted Average Cost of Capital (WACC) | 10.95% |
| Revenue Per Employee | $243,538 |
| Profits Per Employee | -$220,681 |
| Employee Count | 1,200 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Health Catalyst has paid $1.15 million in taxes.
| Income Tax | 1.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.78% in the last 52 weeks. The beta is 1.56, so Health Catalyst's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -41.78% |
| 50-Day Moving Average | 2.00 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 37.85 |
| Average Volume (20 Days) | 917,514 |
Short Selling Information
The latest short interest is 2.99 million, so 3.97% of the outstanding shares have been sold short.
| Short Interest | 2.99M |
| Short Previous Month | 3.65M |
| Short % of Shares Out | 3.97% |
| Short % of Float | 4.98% |
| Short Ratio (days to cover) | 3.94 |
Income Statement
In the last 12 months, Health Catalyst had revenue of $292.25 million and -$264.82 million in losses. Loss per share was -$3.68.
| Revenue | 292.25M |
| Gross Profit | 149.52M |
| Operating Income | -23.52M |
| Pretax Income | -263.67M |
| Net Income | -264.82M |
| EBITDA | 11.77M |
| EBIT | -23.52M |
| Loss Per Share | -$3.68 |
Balance Sheet
The company has $103.44 million in cash and $169.98 million in debt, with a net cash position of -$66.54 million or -$0.88 per share.
| Cash & Cash Equivalents | 103.44M |
| Total Debt | 169.98M |
| Net Cash | -66.54M |
| Net Cash Per Share | -$0.88 |
| Equity (Book Value) | 100.83M |
| Book Value Per Share | 1.35 |
| Working Capital | 156.47M |
Cash Flow
In the last 12 months, operating cash flow was $28.23 million and capital expenditures -$1.21 million, giving a free cash flow of $27.02 million.
| Operating Cash Flow | 28.23M |
| Capital Expenditures | -1.21M |
| Depreciation & Amortization | 35.29M |
| Net Borrowing | -2.29M |
| Free Cash Flow | 27.02M |
| FCF Per Share | $0.36 |
Margins
Gross margin is 51.16%, with operating and profit margins of -8.05% and -90.61%.
| Gross Margin | 51.16% |
| Operating Margin | -8.05% |
| Pretax Margin | -90.22% |
| Profit Margin | -90.61% |
| EBITDA Margin | 4.03% |
| EBIT Margin | -8.05% |
| FCF Margin | 9.25% |
Dividends & Yields
Health Catalyst does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.32% |
| Shareholder Yield | -10.32% |
| Earnings Yield | -206.99% |
| FCF Yield | 21.12% |
Analyst Forecast
The average price target for Health Catalyst is $1.83, which is 7.65% higher than the current price. The consensus rating is "Buy".
| Price Target | $1.83 |
| Price Target Difference | 7.65% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | -10.58% |
| EPS Growth Forecast (3Y) | -36.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Health Catalyst has an Altman Z-Score of -4.4 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.4 |
| Piotroski F-Score | 5 |